# Cytek Biosciences, Inc. (CTKB) earnings: -$66.54M in 2025

URL: https://funkfolio.com/stock/CTKB/earnings

> Cytek Biosciences, Inc. (CTKB) earnings were -$66.54M in fiscal 2025. See 6 fiscal years of history in a chart and a table, and how the figure is calculated.

---

## Cytek Biosciences, Inc. (CTKB) earnings

**Earnings (net income) · fiscal 2025:** -$66.54M year ended Dec 31, 2025

Cytek Biosciences, Inc. (CTKB) reported net income of -$66.54M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$6.02M. Figures as of 17 Nov 2026, 21:22 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **Earnings (net income), fiscal 2025:** -$66.54M
- **Highest on record:** $19.41M fiscal 2020
- **Lowest on record:** -$66.54M fiscal 2025
- **Fiscal years on record:** 6 2020–2025

Figures as of 17 Nov 2026, 21:22 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

### Cytek Biosciences, Inc. earnings, in more detail

Across the 6 fiscal years on record (2020–2025), the highest was $19.41M in fiscal 2020 and the lowest -$66.54M in fiscal 2025.

### Earnings (net income) by fiscal year

### Cytek Biosciences, Inc. earnings, year by year

Cytek Biosciences, Inc. (CTKB) earnings by fiscal year

| Fiscal year | Earnings (net income) | Change | Year ended |
| --- | --- | --- | --- |
| 2025 | -$66.54M | — | Dec 31, 2025 |
| 2024 | -$6.02M | — | Dec 31, 2024 |
| 2023 | -$12.15M | 571.6% down | Dec 31, 2023 |
| 2022 | $2.58M | 14.9% down | Dec 31, 2022 |
| 2021 | $3.03M | 84.4% down | Dec 31, 2021 |
| 2020 | $19.41M | — | Dec 31, 2020 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

### How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

### Cytek Biosciences, Inc., figure by figure

- [Cytek Biosciences, Inc. market cap](https://funkfolio.com/stock/CTKB/market-cap)
- [Cytek Biosciences, Inc. revenue](https://funkfolio.com/stock/CTKB/revenue)
- [Cytek Biosciences, Inc. earnings per share (EPS)](https://funkfolio.com/stock/CTKB/eps)
- [Cytek Biosciences, Inc. P/E ratio](https://funkfolio.com/stock/CTKB/pe-ratio)
- [Cytek Biosciences, Inc. P/S ratio](https://funkfolio.com/stock/CTKB/ps-ratio)
- [Cytek Biosciences, Inc. P/B ratio](https://funkfolio.com/stock/CTKB/pb-ratio)
- [Cytek Biosciences, Inc. free cash flow](https://funkfolio.com/stock/CTKB/free-cash-flow)
- [Cytek Biosciences, Inc. operating margin](https://funkfolio.com/stock/CTKB/operating-margin)
- [Cytek Biosciences, Inc. dividend](https://funkfolio.com/stock/CTKB/dividend)
- [Cytek Biosciences, Inc. shares outstanding](https://funkfolio.com/stock/CTKB/shares-outstanding)
- [Cytek Biosciences, Inc. total debt](https://funkfolio.com/stock/CTKB/total-debt)
- [Cytek Biosciences, Inc. cash on hand](https://funkfolio.com/stock/CTKB/cash)
- [Cytek Biosciences, Inc. total assets](https://funkfolio.com/stock/CTKB/total-assets)
- [Cytek Biosciences, Inc. return on equity (ROE)](https://funkfolio.com/stock/CTKB/roe)
- [Cytek Biosciences, Inc. return on invested capital (ROIC)](https://funkfolio.com/stock/CTKB/roic)

[Cytek Biosciences, Inc. (CTKB) overview: price, valuation and scorecard](https://funkfolio.com/stock/CTKB)

### Cytek Biosciences, Inc. earnings: questions and answers

**What is Cytek Biosciences, Inc.'s net income?**

Cytek Biosciences, Inc. (CTKB) reported net income of -$66.54M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$6.02M.

**What are the highest and lowest net income figures on record for Cytek Biosciences, Inc.?**

Across the 6 fiscal years on record (2020–2025), the highest was $19.41M in fiscal 2020 and the lowest -$66.54M in fiscal 2025.

**How is Cytek Biosciences, Inc.'s net income calculated?**

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

### Learn: earnings

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Revenue vs earnings vs free cash flow: what each tells you](https://funkfolio.com/learn/stocks/revenue-earnings-free-cash-flow)

  Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.

### Cite this page

Funkfolio, “Cytek Biosciences, Inc. (CTKB) earnings”, data as of 17 November 2026. https://funkfolio.com/stock/CTKB/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.
